fidaxomicin

CHMP Recommends Astellas Pharma Europe Ltd.'s (APEL) DIFICLIR for Approval in the EU
Yahoo/PR NewsWire
Sat, 09/24/11 - 12:40 pm
Optimer Pharmaceuticals
Astellas
Dificlir
Clostridium Difficile
fidaxomicin
Labeling and Script Use May Cause Problems For Optimer's New Drug
Seeking Alpha
Fri, 05/27/11 - 08:56 am
Optimer
fidaxomicin
FDA
Clostridium Difficile
Optimer to Co-Market Dificid Drug With Cubist Pharmaceuticals
Bloomberg
Wed, 04/6/11 - 08:18 am
Dificid
Cubist Pharmaceuticals
Optimer
antibiotics
fidaxomicin
Optimer Wins FDA Panel’s Backing for Antibiotic Fidaxomicin
Bloomberg
Tue, 04/5/11 - 09:06 pm
Optimer
FDA
antibiotics
fidaxomicin
advisory panels
Ahead of the Bell: Nasdaq halts Optimer trading
Yahoo/AP
Tue, 04/5/11 - 10:43 am
Optimer
antibiotics
fidaxomicin
Optimer Pharma: FDA Panel Live Blog
TheStreet.com
Tue, 04/5/11 - 08:36 am
FDA
advisory panels
Optimer
antibiotics
fidaxomicin
Optimer Gets Boost From FDA
Minyanville
Sat, 04/2/11 - 10:14 am
Optimer
fidaxomicin
Clostridium Difficile
Optimer Faces Key FDA Review Panel
TheStreet.com
Tue, 03/29/11 - 11:47 am
FDA
Optimer
advisory panels
fidaxomicin
antibiotics
Optimer Pharma: Prime Acquisition Target
Seeking Alpha
Thu, 03/24/11 - 01:46 pm
Optimer
M&A
antidepressants
Viibryd
fidaxomicin
Clinical Data
Forest Labs
Optimer lands $224M licensing pact for promising antibiotic
Fierce Biotech
Mon, 02/7/11 - 11:33 am
antibiotics
Optimer
fidaxomicin
Astellas
Optimer Gets NEJM Power
Forbes
Thu, 02/3/11 - 11:10 am
New England Journal of Medicine
Optimer
fidaxomicin
Clostridium Difficile
Optimer Pharmaceuticals' bacterial infection drug gets 6-month FDA review
Yahoo/AP
Mon, 01/24/11 - 11:46 am
Optimer
FDA
fidaxomicin
Clostridium Difficile
Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
PR Newswire
Sun, 10/24/10 - 12:49 pm
Optimer
Clostridium Difficile
fidaxomicin
Optimer's Fidaxomicin Encourages
Yahoo/Zacks.com
Fri, 09/17/10 - 11:09 am
Optimer
fidaxomicin
Clostridium Difficile
Positive Data from Optimer
Yahoo/Zacks.com
Mon, 04/12/10 - 09:39 am
Optimer
fidaxomicin
Sanofi
ViroPharma
Positive Results from Optimer Pharmaceuticals' Second Phase 3 Study of Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI) Presented at ECCMID
Yahoo/PR NewsWire
Sun, 04/11/10 - 11:30 am
Optimer
fidaxomicin
Clostridium Difficile
Optimer Pharma rises on fidaxomicin study data
Yahoo/AP
Sat, 02/6/10 - 11:54 am
Optimer
C. difficile
fidaxomicin
Additional Data From Fidaxomicin's Phase 3 Study for Clostridium Difficile Infection (CDI) Presented at IDSA Annual Meeting
Yahoo/AP
Sun, 11/1/09 - 09:02 am
fidaxomicin
Optimer
Clostridium Difficile